Valuation: ResMed Inc.

Market Cap 30.91B 27.16B 25.35B 23.27B 43.55B 2,961B 44.63B 301B 118B 1,465B 116B 114B 5,065B P/E 2026 *
20.2x
P/E 2027 * 18.9x
Enterprise Value 30.08B 26.43B 24.67B 22.64B 42.39B 2,881B 43.43B 293B 114B 1,426B 113B 110B 4,929B EV / Sales 2026 *
5.32x
EV / Sales 2027 * 4.9x
Free-Float
75.61%
Yield 2026 *
1.13%
Yield 2027 * 1.22%
1 day+2.89%
3 months-32.82%
6 months-40.29%
Current year-37.45%
Current year 11.85
Extreme 11.85
37.91
1 year 11.85
Extreme 11.85
37.91
3 years 11.85
Extreme 11.85
37.91
5 years 1.9
Extreme 1.9
37.91
10 years 0
Extreme 0
37.91
Manager TitleAgeSince
Chief Executive Officer 53 2013-02-28
Director of Finance/CFO 40 2026-05-03
Compliance Officer - 2017-12-31
Director TitleAgeSince
Director/Board Member 78 2004-12-31
Chairman 53 2023-01-24
Chairman 83 1989-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+2.89%-.--% - - 30.14B
+0.01%+9.50%+19.56%+2.60% 214B
-1.29%+9.69%-5.01%-24.45% 140B
-2.40%+3.64%-28.94%+8.14% 128B
-0.04%+7.14%-56.76%-10.93% 68.46B
+2.49%+1.65%+6.57%+2.41% 48.18B
+4.51%+8.59%-22.65%-28.66% 45.56B
-0.17%+5.13%+17.07%+11.31% 39.69B
-1.15%+2.34%+25.16%+32.79% 37.69B
+0.95%+2.07%+79.21%+1.24% 29.2B
Average +0.55%+5.24%+3.80%-0.62% 83.42B
Weighted average by Cap. -0.15%+6.83%-1.16%-2.72%

Financials

2026 *2027 *
Net sales 5.65B 4.97B 4.63B 4.25B 7.96B 541B 8.16B 54.96B 21.49B 268B 21.22B 20.75B 926B 5.97B 5.24B 4.89B 4.49B 8.41B 572B 8.62B 58.04B 22.7B 283B 22.41B 21.92B 978B
Net income 1.55B 1.36B 1.27B 1.16B 2.18B 148B 2.23B 15.04B 5.88B 73.29B 5.81B 5.68B 253B 1.61B 1.42B 1.32B 1.21B 2.27B 154B 2.33B 15.67B 6.13B 76.38B 6.05B 5.92B 264B
Net Debt -827M -726M -678M -622M -1.16B -79.18B -1.19B -8.04B -3.14B -39.18B -3.1B -3.04B -135B -1.65B -1.45B -1.35B -1.24B -2.32B -158B -2.38B -16.01B -6.26B -78.04B -6.18B -6.05B -270B
Logo ResMed Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
26-07-28 US$0.000000 - 4
26-07-27 US$0.000000 - 2
26-07-23 US$0.000000 - 1
26-07-22 US$0.000000 - 3
26-07-21 US$0.000000 - 2
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
214.29USD
Average target price
248.60USD
Spread / Average Target
+16.01%

Quarterly revenue - Rate of surprise